Wolverine stack
The short answer: The Wolverine stack is an unapproved pairing of BPC-157 and TB-500 sold for injury recovery. As of October 17, 2026 no human trial has tested the pair, and both peptides are prohibited at all times under the 2026 WADA List.
We collect and compare information from public, cited sources. We cannot guarantee that it is complete, current or correct. This is not medical advice. Only a doctor can prescribe, and a doctor should confirm anything you read here before you act on it.
Based on public sources; we cannot guarantee it is correct. Not medical advice. A doctor should prescribe and confirm. Full disclaimer
Wolverine stack at a glance: evidence grade by ingredient
| Ingredient | What it is | Grade | FDA | WADA 2026 |
|---|---|---|---|---|
| BPC-157 | Synthetic 15-amino-acid fragment of a gastric protein | Evidence grade C | Not approved | S0 prohibited |
| TB-500 | Synthetic fragment of thymosin beta-4, a repair-related protein | Evidence grade D | Not approved | S2 prohibited |
| Wolverine stack (the blend) | No published human or animal study of the pair | Evidence grade U | Not approved | Prohibited |
What is in the Wolverine stack?
The Wolverine stack is BPC-157 and TB-500 used together, named after the comic-book character who heals fast. The name is marketing, not a product standard.
What TB-500 on the label actually is
TB-500 is a synthetic fragment linked to the LKKTETQ region of thymosin beta-4. The human trials people cite tested full-length thymosin beta-4 as eye drops, not the fragment sold as TB-500.
Is the Wolverine stack legal, and will it fail a drug test?
Neither peptide is FDA-approved, and neither can be lawfully compounded as of October 17, 2026. In sport, BPC-157 is prohibited under S0 and TB-500 under S2 of the 2026 WADA List, in and out of competition. Anti-doping rules work on strict liability: a positive test counts whatever the label said. The US military's Operation Supplement Safety also lists BPC-157 as prohibited.
What sellers claim vs what has been shown
- Whether the two interact: no study of the pair exists.
- What is actually in products sold online.
- Swelling of the face, lips or throat, trouble breathing, chest pain, a racing heart or fainting. Call 911.
- Redness spreading from an injection site, warmth, pus or a fever. Get same-day care.
- Unsure what you took or whether a reaction is serious: Poison Control 1-800-222-1222 (free, 24 hours).
- Thoughts of harming yourself: call or text 988.
- If you compete in tested sport or serve in the military. Both peptides are prohibited at all times, and testing works on strict liability.
- If you have or have had cancer. Both have a theoretical blood-vessel growth concern.
- If you are under 18. Neither has been studied in young people.
Compare next
- HSS Journal. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review , 2025. PMID 40756949.
- Alternative Therapies in Health and Medicine. Intra-articular injection of BPC 157 for multiple types of knee pain , 2021. PMID 34324435.
- ClinicalTrials.gov. Thymosin beta-4 (RGN-259) eye-drop trials in neurotrophic keratopathy and dry eye .
- US Food and Drug Administration. Pharmacy Compounding Advisory Committee, meeting of July 23-24, 2026: briefing documents and vote record , 2026-07-23.
- World Anti-Doping Agency. 2026 Prohibited List (sections S0 and S2) , 2026-01-01.
- Operation Supplement Safety (US Department of Defense). BPC-157 .